Annual Cash & Cash Equivalents
$74.96 M
+$3.93 M+5.53%
December 31, 2023
Summary
- As of February 27, 2025, TSVT annual cash & cash equivalents is $74.96 million, with the most recent change of +$3.93 million (+5.53%) on December 31, 2023.
- During the last 3 years, TSVT annual cash & cash equivalents has risen by +$74.96 million (+100.00%).
- TSVT annual cash & cash equivalents is now -42.52% below its all-time high of $130.41 million, reached on December 31, 2021.
Performance
TSVT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$59.98 M
-$51.88 M-46.38%
September 30, 2024
Summary
- As of February 27, 2025, TSVT quarterly cash and cash equivalents is $59.98 million, with the most recent change of -$51.88 million (-46.38%) on September 30, 2024.
- Over the past year, TSVT quarterly cash and cash equivalents has dropped by -$30.24 million (-33.52%).
- TSVT quarterly cash and cash equivalents is now -77.86% below its all-time high of $270.89 million, reached on March 31, 2022.
Performance
TSVT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TSVT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.5% | -33.5% |
| 3 y3 years | +100.0% | -15.6% |
| 5 y5 years | - | -15.6% |
TSVT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -42.5% | +5.5% | -77.9% | +5.6% |
| 5 y | 5-year | -42.5% | -100.0% | -77.9% | -100.0% |
| alltime | all time | -42.5% | -100.0% | -77.9% | -100.0% |
2seventy Bio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.98 M(-46.4%) |
| Jun 2024 | - | $111.86 M(+97.0%) |
| Mar 2024 | - | $56.79 M(-24.2%) |
| Dec 2023 | $74.96 M | $74.96 M(-16.9%) |
| Sep 2023 | - | $90.23 M(-6.0%) |
| Jun 2023 | - | $95.99 M(-50.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $193.63 M(+172.6%) |
| Dec 2022 | $71.03 M(-45.5%) | $71.03 M(-44.1%) |
| Sep 2022 | - | $127.02 M(-52.9%) |
| Jun 2022 | - | $269.87 M(-0.4%) |
| Mar 2022 | - | $270.89 M(+107.7%) |
| Dec 2021 | $130.41 M(>+9900.0%) | $130.41 M(>+9900.0%) |
| Dec 2020 | $0.00 | $0.00 |
FAQ
- What is 2seventy bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for 2seventy bio?
- What is 2seventy bio annual cash & cash equivalents year-on-year change?
- What is 2seventy bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for 2seventy bio?
- What is 2seventy bio quarterly cash and cash equivalents year-on-year change?
What is 2seventy bio annual cash & cash equivalents?
The current annual cash & cash equivalents of TSVT is $74.96 M
What is the all time high annual cash & cash equivalents for 2seventy bio?
2seventy bio all-time high annual cash & cash equivalents is $130.41 M
What is 2seventy bio annual cash & cash equivalents year-on-year change?
Over the past year, TSVT annual cash & cash equivalents has changed by +$3.93 M (+5.53%)
What is 2seventy bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TSVT is $59.98 M
What is the all time high quarterly cash and cash equivalents for 2seventy bio?
2seventy bio all-time high quarterly cash and cash equivalents is $270.89 M
What is 2seventy bio quarterly cash and cash equivalents year-on-year change?
Over the past year, TSVT quarterly cash and cash equivalents has changed by -$30.24 M (-33.52%)